Navigation Links
SNM seeks novel approaches to molecular imaging to showcase at annual meeting
Date:9/21/2007

RESTON, Va. -- Attention scientific researchers: SNM invites you to present your molecular imaging studies -- especially those involving non-radioactive molecular imaging techniques and agents -- at the societys 55th Annual Meeting June 1418, 2008, in New Orleans, La. SNM, the worlds largest society for molecular imaging and nuclear medicine professionals, will showcase these studies in a new scientific investigation track called Novel Approaches to Molecular Imaging.

The emerging field of molecular imaging is a multidisciplinary endeavor that draws researchers from fields as diverse as biochemistry, organic chemistry, genetics, bioengineering, optics, medical imaging, medical physics, nuclear medicine and radiation oncology, said SNM President Alexander J. McEwan, who represents more than 16,000 molecular imaging and nuclear medicine professionals. SNM -- with its mission to improve health care by advancing molecular imaging and therapy -- wants to spotlight todays work with imaging agents including contrast agents, nanoparticles, fluorescent dyes and proteins, microbubbles and techniques such as magnetic resonance, spectroscopy, ultrasound, multi-slice computed tomography and optical imaging of bioluminescence and fluorescence, added McEwan, professor and chair of the Department of Oncology, Faculty of Medicine, at the University of Alberta, and director of oncologic imaging at Cross Cancer Institute in Edmonton, Canada.

While the scope of nuclear medicine includes much of what is understood to be molecular imaging, the field is much broader and includes non-radioactive molecular imaging agents and techniques and multimodality investigations, explained Martin G. Pomper, president of SNMs Molecular Imaging Center of Excellence. The purpose of the Novel Approaches to Molecular Imaging track is to offer a venue for such investigations to be presented and discussed, added the professor of radiology at Johns Hopkins Medical Institutions in Baltimore, Md.

Were looking for the brightest researchers and cutting-edge science that show us the possibilities of molecular imaging with personalized medicine, explained Frederic H. Fahey, chair of the societys Scientific Program Committee and the director of nuclear medicine/PET physics at Childrens Hospital Boston and associate professor of radiology at Harvard Medical School. Fahey encourages researchers to submit pre-clinical in vitro or in vivo and clinical studies.

The new scientific track will encompass cardiovascular, neuroscience, oncology, general specialties, instrumentation and data analysis topics and non-radioactive molecular imaging agents. The societys online abstract submitter opens Oct. 25 and closes Jan. 10, 2008. The submission deadline for technologist students is Feb. 7, 2008.

If you have any questions, please contact Heather Jacene, vice chair of the new track, via e-mail at hjacene1@jhmi.edu. For more information about SNM abstract tracks, categories and awards, go online to http://www.snm.org/abstracts.


'/>"/>

Contact: Maryann Verrillo
mverrillo@snm.org
703-652-6773
Society of Nuclear Medicine
Source:Eurekalert

Related medicine news :

1. Consumer group seeks Sibutramine ban
2. Gujarat Seeks To Scale Down Infant Mortality Rate
3. Europe Seeks Indian Expertise
4. Book Seeks To Rehabilitate Soldiers
5. Government Seeks To Wipe Out Prostitution
6. Multiple Sclerosis Patient Seeks Help of Stem Cells
7. Pro-reservation body seeks removal of AIIMS Director
8. AIIMS Doctors Seeks Ramadoss Intervention For Venugopal’s Remova
9. Human Chain Seeks AIIMS Status For Tiruchi Medical College
10. Harney Seeks Approval for New Medical Practitioners Bill
11. Drug Company Seeks Approval for Human Testing of Vaccine against H5N1 Virus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2017)... ... February 26, 2017 , ... IndustryArchive.Org . is announcing ... B2B Marketing. B2B Sellers will now only pay for B.A.N.T. quality sales leads based ... of IndustryArchive.Org, said, “Given the new reality that B2B buyers are controlling the sales ...
(Date:2/25/2017)... ... February 25, 2017 , ... FCPX users now have ... from Pixel Film Studios. With ProSharpen Color users have total control over sharpening amount, ... their color range. With color spectrum tools users can visually see the color range ...
(Date:2/24/2017)... ... February 24, 2017 , ... An in-depth computational analysis of ... of Pittsburgh points to eight genes that may explain why susceptibility to one of ... results of a study published today in the journal npj Schizophrenia. , “There ...
(Date:2/24/2017)... ... February 24, 2017 , ... Healthcare Associates of ... Center at Craig Ranch building at 8080 State Highway 121, Suite 210, McKinney, Texas ... easy access to Highway 121. , As the practice has grown, the need for ...
(Date:2/24/2017)... ... 2017 , ... The International Association of Eating Disorders Professionals (iaedp) announces the ... body image mannequin art competition. Selected from 15 submissions from around the nation, the ... the 31st annual iaedp Symposium, March 22 – 26 in Las Vegas. , This ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... , Australie, le 24 février 2017 ITL Limited, ... santé diversifiée innovante, est ravie d,annoncer les excellents résultats ... la période précédente correspondante. Une présentation complète « Résultats et ... être consultée ici . Faits ... de 2,12 millions $ (Déc. 2015 : 1,04 million $ ; en hausse de ...
(Date:2/24/2017)... , Feb. 23, 2017 ... insights on the various drugs being developed ... covers all the drugs that are in ... Clinical). The pipeline focuses on novel pharmacologic ... antibodies, stem cell therapies, recombinant proteins and ...
(Date:2/24/2017)... Feb. 24, 2017  Xynomic Pharmaceuticals, Inc., an oncology ... it has acquired exclusive worldwide rights to develop, ... HDAC inhibitor targeting hematological and solid tumors. ... 1 and 2 clinical trials of Abexinostat in ... have already been completed, demonstrating that Abexinostat is ...
Breaking Medicine Technology: